Advertisement
Journal Home
Search for

Volume 103, Supplement, Pages S66.e1-S66.e19 (March 2007)


View previous. 15 of 15

Management of salivary hypofunction during and after radiotherapy

Caroline H. Shiboski, DDS, MPH, PhDaCorresponding Author Informationemail address, Tim A. Hodgson, BDS, MB BS, FDS FDS(OM) RCS, MRCP(UK)b, Jonathan A. Ship, DMDc, Morten Schiødt, DDS, DrOdontd

Received 9 November 2006; accepted 9 November 2006.

Salivary hypofunction, the most common complication of high-dose radiation therapy (RT) to the head and neck, has a significant impact on quality of life, and requires careful planning of long-term dental and oral care. This report documents the results and conclusions of an evidence-based literature review on multidisciplinary team management of salivary hypofunction during and after RT. An update is provided on the pathophysiology of salivary hypofunction during and after RT, and recommendations for clinical management. The paper presents aspects managed by dental professionals (use of cholinergic agonists and other saliva stimulants, prevention of hyposalivation-induced rampant caries, and use of saliva substitutes), as well as the role of the radiation oncologist in minimizing salivary gland damage (parotid-sparing RT; cytoprotectants). This summary includes basic science, translational and clinical research topics with respect to radiation-induced salivary hypofunction, and provides an evidence-based management algorithm.

a Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA.

b Oral Medicine, UCL Eastman Dental Institute and UCLH Foundation Trust, Eastman Dental Hospital, London, UK.

c Department of Oral and Maxillofacial Pathology, Radiology, and Medicine; New York University College of Dentistry and the NYU Bluestone Center for Clinical Research, New York, NY.

d Department of Oral and Maxillofacial Surgery, Copenhagen University Hospital, Glostrup, Denmark.

Corresponding Author InformationReprint requests: Caroline H. Shiboski, DDS, MPH, PhD, Department of Orofacial Sciences, Box 0422, Room S612, 513 Parnassus Avenue, University of California San Francisco, San Francisco, CA 94143-0422

PII: S1079-2104(06)00875-4

doi:10.1016/j.tripleo.2006.11.013


View previous. 15 of 15

Advertisement